Dr.Shruti Lanjewar
Purpose: To evaluate efficacy of cyclosporine 0.05% in alleviating dry-eye signs and improving visual quality in moderate to severe dry eye patients after multifocal intraocular lens (IOL) implantation.
Methods:Prospective trial comprised of 16 eyes of 16 moderate to severe dry eye patients scheduled to have phaco with implantation of multifocal IOL who twice-daily cyclosporine 0.05% from 1 month before to 2 months after surgery.
Results:Two months postoperatively treatment with cyclosporine 0.05% significantly improved visual acuity, contrast sensitivity, conjunctival staining, Schirmer scores, tear breakup time and corneal staining. There was also a decrease in OSDI scores. There were no significant adverse effects.
Conclusion:Cyclosporine 0.05% therapy reduced dry-eye signs and improved visual quality after multifocal IOL implantation in moderate to severe dry eye patients.
Leave a Comment